Consonance Capital Management as of Sept. 30, 2020
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 27 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Macrogenics (MGNX) | 11.5 | $94M | 3.7M | 25.19 | |
| GenMark Diagnostics | 9.2 | $75M | 5.3M | 14.20 | |
| Mersana Therapeutics (MRSN) | 7.9 | $65M | 3.5M | 18.62 | |
| Atara Biotherapeutics | 7.4 | $61M | 4.7M | 12.96 | |
| Kadmon Hldgs | 6.7 | $55M | 14M | 3.92 | |
| Aptose Biosciences Com New | 5.8 | $48M | 8.0M | 6.00 | |
| Protagonist Therapeutics (PTGX) | 5.6 | $46M | 2.4M | 19.55 | |
| Compugen Ord (CGEN) | 5.2 | $43M | 2.6M | 16.25 | |
| Kiniksa Pharmaceuticals Com Cl A | 4.4 | $36M | 2.4M | 15.32 | |
| Aprea Therapeutics | 4.3 | $35M | 1.5M | 24.06 | |
| Liminal Biosciences | 4.2 | $34M | 3.1M | 11.13 | |
| Assembly Biosciences | 3.9 | $32M | 2.0M | 16.44 | |
| Tcr2 Therapeutics Inc cs | 3.7 | $31M | 1.5M | 20.32 | |
| Heron Therapeutics (HRTX) | 3.6 | $30M | 2.0M | 14.82 | |
| Springworks Therapeutics (SWTX) | 3.5 | $29M | 603k | 47.67 | |
| Iveric Bio | 2.6 | $22M | 3.8M | 5.64 | |
| Molecular Templates | 2.3 | $19M | 1.7M | 10.92 | |
| Axovant Gene The | 1.8 | $15M | 3.2M | 4.62 | |
| Stereotaxis Com New (STXS) | 1.4 | $11M | 3.1M | 3.58 | |
| Casi Pharmaceuticalsinc Com Stk | 1.2 | $10M | 6.6M | 1.53 | |
| Actinium Pharmaceuticals (ATNM) | 0.9 | $7.7M | 793k | 9.69 | |
| Soleno Therapeutics Com New | 0.9 | $7.6M | 3.0M | 2.51 | |
| Omeros Corporation (OMER) | 0.6 | $4.9M | 484k | 10.10 | |
| Adma Biologics (ADMA) | 0.5 | $3.7M | 1.6M | 2.39 | |
| Deerfield Healthcare Tech Ac Unit 07/16/2025 | 0.3 | $2.7M | 250k | 10.63 | |
| Bctg Acquisition Corp | 0.2 | $1.9M | 180k | 10.36 | |
| Fs Dev Corp Com Cl A | 0.1 | $1.1M | 100k | 11.20 |
